Open original FDA record ↗Recall record
- FDA identifier
- Z-1437-2012
- Company in FDA record
- Teva Pharmaceuticals USA, Inc.
- FDA classification date
- Apr 18, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Lack of assurance of sterility
Source facts
- Action
- Teva Pharmaceuticals USA sent an "URGENT MEDICAL DEVICE RECALL-RETAIL LEVEL" letter dated March 30, 2012. The letter identifies the problem, product, and actions to be taken by the customers. The letter instructs customers to check their inventory and to discontinue distribution of the affected product. A Stock Response Form was enclosed for customers to complete and return via fax to 817-868-5362. Contact Teva Customer Services at 800-545-8800 for questions regarding this notice.
- Initiated
- 2012-03-30
- Root cause
- Material/Component Contamination
- Terminated
- 2012-10-25
- Distribution
- Nationwide Distribution-USA (nationwide) including the states of AL, AZ, CA, CT, DE, FL, GA, IA, IL, KS, KY, LA, MA, MD, MN, MO, NC, ND, NE, NJ, NM, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI and WV and Washington, D.C.
- Recall number
- Z-1437-2012
- Recall status
- Terminated
- CDRH record ID
- 108554
- FDA classified
- 2012-04-18
- Recall event number
- 61622